Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Anemia 1

Interventions

Epoetin Alfa 4epoetin beta 3Lenalidomide 2reolysin 1ibrutinib 1fludarabine phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1continuous erythropoietin receptor activator 1carfilzomib 1auricularum 1alvocidib 1Thalidomide 1Rituximab 1Radiotherapy 1Pharmacogenomic Testing 1Iron-Dextran Complex 1Ferric Oxide, Saccharated 1Dexamethasone 1Cyclosporine 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1CT-P10 1Brachytherapy 1Biopsy 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anemia × Ferric Oxide, Saccharated × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡